Internal Server Error

List of Ipsen's Acquisitions

lockFilter this list
Ipsen has made a total of 11 acquisitions. These transactions span 9 sectors, including Oncology, Immunotherapy, and Genomics, across 7 countries, most notably United Kingdom, United States, and France. Peak acquisition activity occurred in 2026 and 2015 with 2 acquisitions each, while 1 occurred in 2025. From 2020 to 2025, the average number of acquisitions per year was 0.6, and the company has completed 2 acquisitions as of the current calendar year. The most recent acquisition is Memo Therapeutics, a Schlieren-based developer of antibodies for treating infectious diseases and cancer founded in 2012. This transaction was completed in July 2026.

Here's the year on year acquisition history of Ipsen:

Year on year acquisition history of Ipsen202620252023202220192017Acquisitions Round Date (Yearly)0123
  • Number of Total Acquisitions
Year
# Acquisitions
2026
2
2025
1
2023
1
2022
1
2019
1
2017
1
2015
2
2013
1
2008
1

Recent acquisitions by Ipsen

Ipsen's most recent acquisition - Memo Therapeutics is a Developer of antibodies for treating infectious diseases and cancer, founded in 2012 and located in Schlieren. Ipsen acquired it in July 2026 for a price of $*****.

Here is the list of all acquisitions by Ipsen sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jul 01, 2026
drhz
odxa
66
302
Jun 29, 2026
ywas
grnu
12
714
Dec 15, 2025
uwkn
syqf
23
284
Jan 09, 2023
cbah
lalt
56
297
Jun 27, 2022
zzwr
qrom
90
243

View the full list of acquisitions

Sign Up for Free

News related to Ipsen's acquisitions

lockFilter this list

Media has covered Ipsen for a total of 55 events in the last 1 year, 7 of them have been about acquisition activity.

View More Ipsen Recent News

FAQs about Acquisitions by Ipsen

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford